Magistra - Pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Magistra - Pharma
Largest movements
- Cash +€76,465
up €76,465 (+147%), from €51,896 to €128,362
mainly Receivables within one year (+€44,704) and Net result for the year (+€35,189)
- Receivables within one year -€44,704
down €44,704 (-28.4%), from €157,353 to €112,649
of which Other amounts receivable: -€49,273
- Stocks and contracts -€29,453
down €29,453 (-35.3%), from €83,443 to €53,990
- Tangible fixed assets -€10,638
down €10,638 (-54.2%), from €19,638 to €9,000
- Profit (loss) carried forward +€35,189
up €35,189 (+26.6%), from €132,194 to €167,383
- Trade debts -€19,530
down €19,530 (-14.5%), from €134,581 to €115,052
- Current portion of long-term debt -€18,740
no longer reported in 2025 (was €18,740)
- Tax, wage and social debts -€4,795
down €4,795 (-75.3%), from €6,365 to €1,570
of which Remuneration and social security: -€4,759
- Staff costs -€51,908
down €51,908 (-43.3%), from €119,855 to €67,947
- Gross operating margin +€11,259
up €11,259 (+10.5%), from €106,868 to €118,127
- Depreciation +€6,983
up €6,983 (+191%), from €3,655 to €10,638
- Financial charges +€3,100
up €3,100 (+247%), from €1,253 to €4,354
- Financial income -€1,808
no longer reported in 2025 (was €1,808)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €312,331 | €304,456 | -€7,876 | -2.5% |
| Fixed assets | 21/28 | €19,638 | €9,000 | -€10,638 | -54.2% |
| Tangible fixed assets | 22/27 | €19,638 | €9,000 | -€10,638 | -54.2% |
| Land and buildings | 22 | €4,075 | €2,339 | -€1,736 | -42.6% |
| Plant, machinery and equipment | 23 | €4,081 | - | -€4,081 | |
| Other tangible fixed assets | 26 | €11,483 | €6,661 | -€4,821 | -42.0% |
| Current assets | 29/58 | €292,693 | €295,455 | +€2,762 | +0.9% |
| Stocks and contracts in progress | 3 | €83,443 | €53,990 | -€29,453 | -35.3% |
| Stocks | 30/36 | €83,443 | €53,990 | -€29,453 | -35.3% |
| Amounts receivable within one year | 40/41 | €157,353 | €112,649 | -€44,704 | -28.4% |
| Trade receivables | 40 | €30,274 | €34,842 | +€4,569 | +15.1% |
| Other amounts receivable | 41 | €127,080 | €77,807 | -€49,273 | -38.8% |
| Cash at bank and in hand | 54/58 | €51,896 | €128,362 | +€76,465 | +147% |
| Deferred charges and accrued income | 490/1 | - | €454 | +€454 | |
| Total equity and liabilities | 10/49 | €312,331 | €304,456 | -€7,876 | -2.5% |
| Equity | 10/15 | €152,645 | €187,834 | +€35,189 | +23.1% |
| Contributions | 10/11 | €18,592 | €18,592 | = | 0.0% |
| Reserves | 13 | €1,859 | €1,859 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,859 | €1,859 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,859 | €1,859 | = | 0.0% |
| Profit (loss) carried forward | 14 | €132,194 | €167,383 | +€35,189 | +26.6% |
| Amounts payable | 17/49 | €159,686 | €116,622 | -€43,065 | -27.0% |
| Amounts payable within one year | 42/48 | €159,686 | €116,622 | -€43,065 | -27.0% |
| Current portion of amounts payable after more than one year | 42 | €18,740 | - | -€18,740 | |
| Trade debts | 44 | €134,581 | €115,052 | -€19,530 | -14.5% |
| Suppliers | 440/4 | €134,581 | €115,052 | -€19,530 | -14.5% |
| Taxes, remuneration and social security | 45 | €6,365 | €1,570 | -€4,795 | -75.3% |
| Taxes | 450/3 | €1,377 | €1,341 | -€36 | -2.6% |
| Remuneration and social security | 454/9 | €4,988 | €229 | -€4,759 | -95.4% |
| Remuneration, social security and pensions | 62 | €119,855 | €67,947 | -€51,908 | -43.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,655 | €10,638 | +€6,983 | +191% |
| Gross operating margin | 9900 | €106,868 | €118,127 | +€11,259 | +10.5% |
| Operating profit (loss) | 9901 | -€16,641 | €39,543 | +€56,184 | |
| Financial income | 75/76B | €1,808 | - | -€1,808 | |
| Recurring financial income | 75 | €1,808 | - | -€1,808 | |
| Financial charges | 65/66B | €1,253 | €4,354 | +€3,100 | +247% |
| Recurring financial charges | 65 | €1,253 | €4,354 | +€3,100 | +247% |
| Profit (loss) for the period before taxes | 9903 | -€16,086 | €35,189 | +€51,276 | |
| Profit (loss) for the period | 9904 | -€16,086 | €35,189 | +€51,276 | |
| Profit (loss) for the period to be appropriated | 9905 | -€16,086 | €35,189 | +€51,276 |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.